Pfizer says FDA OKs updated infection vaccine

Feb 24, 2010 By MATTHEW PERRONE , AP Business Writer

(AP) -- Pfizer says the Food and Drug Administration has approved an updated version of its best-selling infection vaccine for children.

Prevnar 13 is intended to reduce the risk of infection by 13 varieties of pneumococcal disease, which causes ear infections, meningitis and . The new vaccine adds protection against six additional varieties of bacterial infection compared with the current vaccine.

The vaccine, developed by Wyeth, is the first product to win FDA approval since Pfizer acquired Wyeth last year.

With sales of $2.7 billion in 2008, Prevnar was considered a key product in Pfizer's decision to purchase Wyeth for $68 billion.

Explore further: Seniors successfully withdraw from meds

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA reviews update to Pfizer vaccine for kids

Nov 16, 2009

(AP) -- Federal health officials on Monday questioned whether to approve an updated version of Pfizer's best-selling anti-infection vaccine for children, despite company studies that failed to meet certain goals.

Wyeth seeking approval for advanced infant vaccine

Mar 31, 2009

(AP) -- Drugmaker Wyeth on Tuesday sought U.S. approval to sell a new version of its blockbuster infant vaccine Prevnar that protects against more strains of a bacteria that causes pneumonia and other diseases.

FDA expands meningitis vaccine approval

Oct 22, 2007

The U.S. Food and Drug Administration has expanded approval for the use of Menactra, a bacterial meningitis vaccine, to children ages 2 to 10.

Recommended for you

Seniors successfully withdraw from meds

5 hours ago

Elderly people have proved receptive to being de-prescribed medications, as part of a trial aimed at assessing the feasibility of withdrawal of medications among older people.

Flu vaccine for expectant moms a top priority

23 hours ago

Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.

Experts want restrictions on testosterone drug use (Update)

Sep 17, 2014

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...

User comments : 0